AAPL337.39-7.24 (-2.10%) ▼|ABBV288.90-5.99 (-2.03%) ▼|ABT109.79+3.59 (+3.38%) ▲|ACN261.94+3.70 (+1.43%) ▲|ADBE252.01+1.78 (+0.71%) ▲|AMAT378.43-11.66 (-2.99%) ▼|AMD472.49-32.31 (-6.40%) ▼|AMGN467.83+1.82 (+0.39%) ▲|AMT188.27+0.49 (+0.26%) ▲|AMZN248.18+7.83 (+3.26%) ▲|AVGO325.90-0.18 (-0.06%) ▼|AXP329.70+10.59 (+3.32%) ▲|BA175.67+4.12 (+2.40%) ▲|BAC49.81-0.20 (-0.40%) ▼|BKNG154.37+6.24 (+4.21%) ▲|BLK1,168.40+20.86 (+1.82%) ▲|BMY62.81+0.33 (+0.52%) ▲|BNY148.19+1.08 (+0.73%) ▲|BRK-B554.74+12.25 (+2.26%) ▲|C123.42+1.45 (+1.19%) ▲|CAT613.55-9.20 (-1.48%) ▼|CL97.33+2.04 (+2.14%) ▲|CMCSA23.67+0.45 (+1.92%) ▲|COF211.51+6.66 (+3.25%) ▲|COP147.43-6.60 (-4.28%) ▼|COST1,038.61+26.33 (+2.60%) ▲|CRM226.94-2.23 (-0.97%) ▼|CSCO102.59-1.92 (-1.84%) ▼|CVS89.13-1.12 (-1.24%) ▼|CVX228.27-7.25 (-3.08%) ▼|DE663.29-12.20 (-1.81%) ▼|DHR228.98-3.25 (-1.40%) ▼|DIS113.11+2.17 (+1.96%) ▲|DUK128.30+0.91 (+0.71%) ▲|EMR166.80+1.86 (+1.13%) ▲|FDX319.68+6.40 (+2.04%) ▲|GD372.72+0.13 (+0.03%) ▲|GE315.16+13.36 (+4.43%) ▲|GEV870.82+12.95 (+1.51%) ▲|GILD170.46-0.22 (-0.13%) ▼|GM89.40+2.00 (+2.29%) ▲|GOOG281.17+2.95 (+1.06%) ▲|GOOGL282.42+2.58 (+0.92%) ▲|GS901.65+7.10 (+0.79%) ▲|HD339.94+10.74 (+3.26%) ▲|HON223.63+5.30 (+2.43%) ▲|IBM254.72-3.10 (-1.20%) ▼|INTC60.28-5.48 (-8.33%) ▼|INTU353.03+11.94 (+3.50%) ▲|ISRG436.96+4.95 (+1.15%) ▲|JNJ271.12-2.08 (-0.76%) ▼|JPM340.93+3.89 (+1.15%) ▲|KO95.95+1.87 (+1.98%) ▲|LIN521.88+7.64 (+1.49%) ▲|LLY1,419.18+1.64 (+0.12%) ▲|LMT642.99+6.04 (+0.95%) ▲|LOW217.17+8.10 (+3.87%) ▲|LRCX227.62-11.49 (-4.81%) ▼|MA657.73+19.72 (+3.09%) ▲|MCD264.22+6.10 (+2.36%) ▲|MDLZ66.08+1.14 (+1.76%) ▲|MDT99.07+2.53 (+2.62%) ▲|META610.48-4.51 (-0.73%) ▼|MMM178.46+4.12 (+2.36%) ▲|MO77.01-1.02 (-1.31%) ▼|MRK149.04-0.49 (-0.32%) ▼|MS186.15+1.85 (+1.00%) ▲|MSFT512.34-9.57 (-1.83%) ▼|MU838.73-46.01 (-5.20%) ▼|NEE85.22+1.51 (+1.80%) ▲|NFLX62.39+0.31 (+0.49%) ▲|NKE39.17+0.50 (+1.28%) ▲|NOW106.76+1.64 (+1.56%) ▲|NVDA203.93-0.72 (-0.35%) ▼|ORCL120.20-10.47 (-8.01%) ▼|PEP139.85+2.51 (+1.83%) ▲|PFE30.91+0.39 (+1.28%) ▲|PG163.80+2.23 (+1.38%) ▲|PLTR181.57-2.54 (-1.38%) ▼|PM207.77-1.02 (-0.49%) ▼|QCOM164.10-0.69 (-0.42%) ▼|RTX202.53+2.73 (+1.37%) ▲|SBUX104.58+0.93 (+0.89%) ▲|SCHW88.88+0.83 (+0.94%) ▲|SO94.49+0.78 (+0.83%) ▲|SPG222.66+4.91 (+2.25%) ▲|T21.45+0.04 (+0.16%) ▲|TMO685.17-11.83 (-1.70%) ▼|TMUS159.14+2.70 (+1.73%) ▲|TSLA403.37+3.56 (+0.89%) ▲|TXN306.78+5.94 (+1.97%) ▲|UBER66.74+1.49 (+2.28%) ▲|UNH401.58-5.40 (-1.33%) ▼|UNP307.37+3.37 (+1.11%) ▲|UPS109.65+1.40 (+1.29%) ▲|USB60.50+1.05 (+1.77%) ▲|V425.74+12.15 (+2.94%) ▲|VZ45.10+0.37 (+0.82%) ▲|WFC85.75+2.35 (+2.82%) ▲|WMT127.33+3.82 (+3.09%) ▲|XOM180.48-6.77 (-3.62%) ▼|AAPL337.39-7.24 (-2.10%) ▼|ABBV288.90-5.99 (-2.03%) ▼|ABT109.79+3.59 (+3.38%) ▲|ACN261.94+3.70 (+1.43%) ▲|ADBE252.01+1.78 (+0.71%) ▲|AMAT378.43-11.66 (-2.99%) ▼|AMD472.49-32.31 (-6.40%) ▼|AMGN467.83+1.82 (+0.39%) ▲|AMT188.27+0.49 (+0.26%) ▲|AMZN248.18+7.83 (+3.26%) ▲|AVGO325.90-0.18 (-0.06%) ▼|AXP329.70+10.59 (+3.32%) ▲|BA175.67+4.12 (+2.40%) ▲|BAC49.81-0.20 (-0.40%) ▼|BKNG154.37+6.24 (+4.21%) ▲|BLK1,168.40+20.86 (+1.82%) ▲|BMY62.81+0.33 (+0.52%) ▲|BNY148.19+1.08 (+0.73%) ▲|BRK-B554.74+12.25 (+2.26%) ▲|C123.42+1.45 (+1.19%) ▲|CAT613.55-9.20 (-1.48%) ▼|CL97.33+2.04 (+2.14%) ▲|CMCSA23.67+0.45 (+1.92%) ▲|COF211.51+6.66 (+3.25%) ▲|COP147.43-6.60 (-4.28%) ▼|COST1,038.61+26.33 (+2.60%) ▲|CRM226.94-2.23 (-0.97%) ▼|CSCO102.59-1.92 (-1.84%) ▼|CVS89.13-1.12 (-1.24%) ▼|CVX228.27-7.25 (-3.08%) ▼|DE663.29-12.20 (-1.81%) ▼|DHR228.98-3.25 (-1.40%) ▼|DIS113.11+2.17 (+1.96%) ▲|DUK128.30+0.91 (+0.71%) ▲|EMR166.80+1.86 (+1.13%) ▲|FDX319.68+6.40 (+2.04%) ▲|GD372.72+0.13 (+0.03%) ▲|GE315.16+13.36 (+4.43%) ▲|GEV870.82+12.95 (+1.51%) ▲|GILD170.46-0.22 (-0.13%) ▼|GM89.40+2.00 (+2.29%) ▲|GOOG281.17+2.95 (+1.06%) ▲|GOOGL282.42+2.58 (+0.92%) ▲|GS901.65+7.10 (+0.79%) ▲|HD339.94+10.74 (+3.26%) ▲|HON223.63+5.30 (+2.43%) ▲|IBM254.72-3.10 (-1.20%) ▼|INTC60.28-5.48 (-8.33%) ▼|INTU353.03+11.94 (+3.50%) ▲|ISRG436.96+4.95 (+1.15%) ▲|JNJ271.12-2.08 (-0.76%) ▼|JPM340.93+3.89 (+1.15%) ▲|KO95.95+1.87 (+1.98%) ▲|LIN521.88+7.64 (+1.49%) ▲|LLY1,419.18+1.64 (+0.12%) ▲|LMT642.99+6.04 (+0.95%) ▲|LOW217.17+8.10 (+3.87%) ▲|LRCX227.62-11.49 (-4.81%) ▼|MA657.73+19.72 (+3.09%) ▲|MCD264.22+6.10 (+2.36%) ▲|MDLZ66.08+1.14 (+1.76%) ▲|MDT99.07+2.53 (+2.62%) ▲|META610.48-4.51 (-0.73%) ▼|MMM178.46+4.12 (+2.36%) ▲|MO77.01-1.02 (-1.31%) ▼|MRK149.04-0.49 (-0.32%) ▼|MS186.15+1.85 (+1.00%) ▲|MSFT512.34-9.57 (-1.83%) ▼|MU838.73-46.01 (-5.20%) ▼|NEE85.22+1.51 (+1.80%) ▲|NFLX62.39+0.31 (+0.49%) ▲|NKE39.17+0.50 (+1.28%) ▲|NOW106.76+1.64 (+1.56%) ▲|NVDA203.93-0.72 (-0.35%) ▼|ORCL120.20-10.47 (-8.01%) ▼|PEP139.85+2.51 (+1.83%) ▲|PFE30.91+0.39 (+1.28%) ▲|PG163.80+2.23 (+1.38%) ▲|PLTR181.57-2.54 (-1.38%) ▼|PM207.77-1.02 (-0.49%) ▼|QCOM164.10-0.69 (-0.42%) ▼|RTX202.53+2.73 (+1.37%) ▲|SBUX104.58+0.93 (+0.89%) ▲|SCHW88.88+0.83 (+0.94%) ▲|SO94.49+0.78 (+0.83%) ▲|SPG222.66+4.91 (+2.25%) ▲|T21.45+0.04 (+0.16%) ▲|TMO685.17-11.83 (-1.70%) ▼|TMUS159.14+2.70 (+1.73%) ▲|TSLA403.37+3.56 (+0.89%) ▲|TXN306.78+5.94 (+1.97%) ▲|UBER66.74+1.49 (+2.28%) ▲|UNH401.58-5.40 (-1.33%) ▼|UNP307.37+3.37 (+1.11%) ▲|UPS109.65+1.40 (+1.29%) ▲|USB60.50+1.05 (+1.77%) ▲|V425.74+12.15 (+2.94%) ▲|VZ45.10+0.37 (+0.82%) ▲|WFC85.75+2.35 (+2.82%) ▲|WMT127.33+3.82 (+3.09%) ▲|XOM180.48-6.77 (-3.62%) ▼|
19.6 C
New York
Monday, November 2, 2026

Tag: center

newsFORsourcecompanycontentinformationreleases1market

MIDAS IMMERSION COOLING LAUNCHES INTERACTIVE TCO CALCULATOR TO QUANTIFY ENERGY, SPACE & COST SAVINGS

AUSTIN, Texas, July 18, 2025 /PRNewswire/ -- Midas Immersion Cooling today unveiled its Total Cost of Ownership (TCO) Calculator—an intuitive tool that enables data center operators to model and compare the lifetime savings of full-immersion...

MIDAS IMMERSION COOLING UNVEILS NEW FULL MAINTENANCE SUITE FOR LIQUID-IMMERSION DATA CENTERS

Includes Cordless Server Lift and XCI Byte Bath to Streamline Wear-Free Operations AUSTIN, Texas, July 18, 2025 /PRNewswire/ -- Midas Immersion Cooling today announced the launch of its all-in-one Maintenance Suite designed specifically for full immersion data centers. This turnkey solution equips...

Lowe’s Foundation Investment in Solving Skilled Trades Labor Shortage Grows to $43 Million

Third cohort of community and technical colleges grant recipients will launch and expand new training programs for thousands of aspiring tradespeople MOORESVILLE, N.C., July 18,...

Duke Energy prepares for potential severe storms in Indiana, urges customers to be ready

PLAINFIELD, Ind., July 18, 2025 /PRNewswire/ -- Duke Energy is monitoring forecasts and preparing for potential severe weather, including strong thunderstorms and damaging winds,...

Best Financial Modeling Course (2025): Corporate Finance Institute Recognized as Top Financial Training Program in Report by Expert Consumers

NEW YORK, July 18, 2025 /PRNewswire/ -- The Financial Modeling & Valuation Analyst (FMVA®) certification by Corporate Finance Institute (CFI) has been named the...

Berks Homes Unveils Elizabeth Village: A New Townhome Community in Lower Paxton Township, Harrisburg, PA

HARRISBURG, Pa., July 18, 2025 /PRNewswire/ -- Berks Homes, a trusted local builder for over 50 years, is excited to announce the grand opening...

Monster Energy’s UNLEASHED Podcast Welcomes BMX Athletes Jamie Bestwick and Andy Buckworth on Special Live Episode at X Games Salt Lake City 2025

Episode 505 of the Sports and Pop Culture Podcast Recorded Live at X Games Salt Lake City 2025 SALT LAKE CITY, July 18, 2025 /PRNewswire/...

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – 
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – 
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

LOVESAC AND VAN LEEUWEN UNVEIL LIMITED-EDITION COLLABORATION AHEAD OF NATIONAL ICE CREAM DAY

The brands are teaming up to celebrate 10 years of Van Leeuwen's fan-favorite Honeycomb flavor with custom CitySac Covers, $3 scoops, giveaways and a celebration in...

Muscle Gain & Strength Supplements: How CrazyBulk Muscle Building Supplements Boost Strength and Maximize Muscle Performance Fast

Explore how CrazyBulk legal muscle building supplements power muscle gain, improve muscle strength, and unlock next-level muscle performance in 2025. 
Explore how CrazyBulk legal muscle building supplements power muscle gain, improve muscle strength, and unlock next-level muscle performance in 2025.

Leoch Battery Unveils All-Scenario Smart Energy Solutions at The Battery Show Asia 2025

HONG KONG, July 18, 2025 /PRNewswire/ -- As a Strategic Partner of The Battery Show Asia 2025, Leoch Battery took center stage today at the AsiaWorld-Expo,...

Leoch Battery Unveils All-Scenario Smart Energy Solutions at The Battery Show Asia 2025

HONG KONG, July 18, 2025 /PRNewswire/ -- As a Strategic Partner of The Battery Show Asia 2025, Leoch Battery took center stage today at the AsiaWorld-Expo,...

Leoch Battery Unveils All-Scenario Smart Energy Solutions at The Battery Show Asia 2025

HONG KONG, July 18, 2025 /PRNewswire/ -- As a Strategic Partner of The Battery Show Asia 2025, Leoch Battery took center stage today at the AsiaWorld-Expo,...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCenter

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers